Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Vasa DenticityNSE:DENTALKART +3.75%75 EBITDA Margin % is 3.17% as of Mar. 2026, which is 53% below its 10-year median of 6.73. GuruFocus rates NSE:DENTALKART with a GF Score™ of 75/100 and a GF Value™ of ₹954.30 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 119 Medical Distribution companies, Vasa Denticity ranks better than 59.66% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Vasa Denticity's EBITDA for the
three
months ended in Mar. 2026 was ₹23 Mil. Vasa Denticity's Revenue for the
three
months ended in Mar. 2026 was ₹733 Mil. Therefore, Vasa Denticity's EBITDA margin for the quarter that ended in Mar. 2026 was 3.17%.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Vasa Denticity EBITDA Margin % Related Terms
Vasa Denticity EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Vasa Denticity's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:DENTALKART vs MCK, COR, CAH: EBITDA Margin % Comparison
For the Medical Distribution subindustry, Vasa Denticity's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vasa Denticity EBITDA Margin % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Vasa Denticity's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Vasa Denticity's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vasa Denticity (NSE:DENTALKART) has a EBITDA Margin % of 3.17% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Vasa Denticity and its competitors. This is 53% below median its historical median of 6.73. Over the past decade, Vasa Denticity's EBITDA Margin % has ranged from 0.75 to 11.92. According to the industry distribution chart, Vasa Denticity ranks #48 out of 119 companies in the Medical Distribution industry, placing it in the top 40.3%.
Is Vasa Denticity's EBITDA Margin % too high?
Vasa Denticity's current EBITDA Margin % of 3.17% is 53% below median its 10-year median of 6.73. Over the past 10 years, this metric has ranged from a low of 0.75 to a high of 11.92. The Medical Distribution industry median EBITDA Margin % is 4.28. Vasa Denticity's value of 3.17% is 25.9% below this industry median. Based on the distribution chart, Vasa Denticity ranks #48 out of 119 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Vasa Denticity has a GF Score™ of 75/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Vasa Denticity's EBITDA Margin % compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Vasa Denticity ranks #48 out of 119 companies for EBITDA Margin %. This puts Vasa Denticity in the upper half of its industry. The industry median EBITDA Margin % is 4.28. Vasa Denticity's value of 3.17% is 25.9% below this benchmark. Historically, Vasa Denticity's own EBITDA Margin % has ranged from 0.75 to 11.92 over the past decade. While the company's 10-year median is 6.73 vs. the industry median of 4.28, Vasa Denticity has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Distribution company?
The median EBITDA Margin % among Medical Distribution companies is 4.28, based on 119 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vasa Denticity's current EBITDA Margin % of 3.17% is 25.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Vasa Denticity and its competitors. For the Medical Distribution industry, the median EBITDA Margin % is 4.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vasa Denticity's current EBITDA Margin % is 3.17%, which is 53% below median its own 10-year median of 6.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vasa Denticity stock overvalued right now?
Based on GuruFocus' analysis, Vasa Denticity (NSE:DENTALKART) is currently considered Possible Value Trap. The stock's GF Value™ is ₹954.30, compared to a current price of ₹408.55 — trading 57.2% below its estimated fair value. The current EBITDA Margin % is 3.17%, which is 53% below median its 10-year median of 6.73 and 25.9% below the Medical Distribution industry median of 4.28. Vasa Denticity's overall GF Score™ is 75/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Vasa Denticity (NSE:DENTALKART), the current EBITDA Margin % is 3.17% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vasa Denticity (NSE:DENTALKART) Overvalued in 2026?
Based on GuruFocus' analysis, Vasa Denticity stock appears to be undervalued.
The current stock price of ₹408.55 is trading 57.2% below its estimated GF Value™ of ₹954.30.
GuruFocus considers Vasa Denticity to be Possible Value Trap.
Key valuation signals for NSE:DENTALKART:
EBITDA Margin %: 3.17% (53% below median its 10-year median of 6.73)
GF Value™: ₹954.30 vs. price of ₹408.55 (57.2% below fair value)
Industry Position: 25.9% below the Medical Distribution median (#48 of 119)
No single metric tells the full story. See the NSE:DENTALKART stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vasa Denticity Ltd is engaged in marketing and distributing a comprehensive portfolio of dental products, including consumables, instruments, equipment, and accessories for diagnosing, treating, and preventing dental conditions, as well as improving the aesthetics of the human smile through the online portal Dentalkart.com. The company's products include instruments, disinfectant tools, sterilizing equipment, impression materials, temporary materials for tooth filling, and others.
75GF Score
Get the complete analysis for NSE:DENTALKART
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:DENTALKART has been successfully added to your 
